Category: Health Autonomy

Bribery. Action Alert! Separate reports have surfaced that demonstrate both doctors and politicians are on opioid-makers’ pay roll. In return, it appears as though doctors have prescribed more opioids and lawmakers have backed legislation to make it harder to combat the opioid crisis. This is cronyism 101. First, the doctors. Researchers have reported evidence that… Continue reading What do Opioids, Politicians, and Your Doctor Have in Common?

Thanks to ANH member activism over many years, Congress has finally approved Right to Try legislation. Now we need to expand it. Action Alert! Recently, the House of Representatives approved legislation that expands access to experimental drugs for terminally ill patients who have exhausted all other treatment options. It also frees drug companies from liability where… Continue reading Finally! Some Relief for Dying Patients

ANH members played a key role in thwarting efforts to eliminate access to personalized medicine. Two years ago, the FDA released a draft guidance saying that a compounding pharmacy (a pharmacy that makes customized medicines for individual patients) cannot register as both an “outsourcing” (503B) and a traditional (503A) facility. We issued an action alert… Continue reading Update: Victory in the War on Natural Medicine!

Consumers Down Under will have access to more information about alternative medicines. A bill was recently approved in Australia that loosens some of the regulations governing advertising claims made by producers of alternative and complementary products. The Therapeutic Goods Amendment Bill 2017 creates a list of “permitted indications” which can be used in advertising without… Continue reading A Step Towards Health Freedom in Australia

One person’s health care crisis is Big Pharma’s golden opportunity. From Stat News: The White House’s national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its use. Federal… Continue reading More Opioid Crisis Cronyism

We have safer (and better) answers. But will the government spread the good news? Action Alert! A new study suggests that, if started early enough, a daily regimen of non-prescription ibuprofen (a non-steroidal anti-inflammatory drug, or NSAID) can prevent the onset of Alzheimer’s disease. Whether or not it’s true, it’s a dangerous prescription—especially considering there are… Continue reading Forget This Dangerous Alzheimer’s Treatment

The National Institutes of Health (NIH) sought funding for an alcohol study—from the alcohol industry. From the Washington Examiner: Scientists and officials from the National Institutes of Health worked to solicit donations from the alcohol industry for a study they said would likely conclude that moderate drinking is healthy, according to a new report. The… Continue reading NIH’s Drunken (And Corrupt) Science

Don’t let FDA stifle free speech and suppress the scientific evidence that vitamin D helps prevent preterm births. Action Alert! As we reported recently, Ocean Spray’s petition for a qualified health claim for cranberry products and reduced risk of urinary tract infections demonstrates the horrible track record FDA has in allowing free speech about the benefits of… Continue reading FDA Censorship Could Impact Preterm Births

Studying a food turns it into a drug? Action Alert! An FDA supplement policy infringes on free speech and makes it more difficult to study the health benefits of food and food supplements. Help us fight back! For years, ANH has fought against the federal government’s censorship of free speech about the benefits of food and… Continue reading Tell FDA: Supplements are Not Drugs

FDA’s treatment of fruit illustrates what scientific censorship looks like. Action Alert!  The FDA is currently considering a petition from Ocean Spray, the juice company, to allow a qualified health claim that cranberries can reduce the risk of recurrent urinary tract infections (UTIs) in healthy women. Given the way the FDA protects Big Pharma’s monopoly… Continue reading Will FDA Censor the Cranberry?